rs139029314

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_198586.3(NHLRC1):​c.32C>A​(p.Ala11Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00225 in 1,596,788 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0018 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0023 ( 7 hom. )

Consequence

NHLRC1
NM_198586.3 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:9

Conservation

PhyloP100: 0.553
Variant links:
Genes affected
NHLRC1 (HGNC:21576): (NHL repeat containing E3 ubiquitin protein ligase 1) The protein encoded by this gene is a single subunit E3 ubiquitin ligase. Laforin is polyubiquitinated by the encoded protein. Defects in this intronless gene lead to an accumulation of laforin and onset of Lafora disease, also known as progressive myoclonic epilepsy type 2 (EPM2).[provided by RefSeq, Mar 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0068249106).
BP6
Variant 6-18122575-G-T is Benign according to our data. Variant chr6-18122575-G-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 167350.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=3, Benign=4}. Variant chr6-18122575-G-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00175 (267/152342) while in subpopulation AMR AF= 0.00307 (47/15306). AF 95% confidence interval is 0.00248. There are 0 homozygotes in gnomad4. There are 112 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 7 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
NHLRC1NM_198586.3 linkuse as main transcriptc.32C>A p.Ala11Glu missense_variant 1/1 ENST00000340650.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
NHLRC1ENST00000340650.6 linkuse as main transcriptc.32C>A p.Ala11Glu missense_variant 1/1 NM_198586.3 P1

Frequencies

GnomAD3 genomes
AF:
0.00175
AC:
267
AN:
152224
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000579
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00307
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00281
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.00140
AC:
311
AN:
221370
Hom.:
1
AF XY:
0.00129
AC XY:
159
AN XY:
123124
show subpopulations
Gnomad AFR exome
AF:
0.000594
Gnomad AMR exome
AF:
0.00235
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000996
Gnomad FIN exome
AF:
0.0000874
Gnomad NFE exome
AF:
0.00211
Gnomad OTH exome
AF:
0.00158
GnomAD4 exome
AF:
0.00231
AC:
3330
AN:
1444446
Hom.:
7
Cov.:
35
AF XY:
0.00220
AC XY:
1581
AN XY:
718970
show subpopulations
Gnomad4 AFR exome
AF:
0.000239
Gnomad4 AMR exome
AF:
0.00251
Gnomad4 ASJ exome
AF:
0.000115
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000580
Gnomad4 FIN exome
AF:
0.0000800
Gnomad4 NFE exome
AF:
0.00275
Gnomad4 OTH exome
AF:
0.00239
GnomAD4 genome
AF:
0.00175
AC:
267
AN:
152342
Hom.:
0
Cov.:
33
AF XY:
0.00150
AC XY:
112
AN XY:
74502
show subpopulations
Gnomad4 AFR
AF:
0.000577
Gnomad4 AMR
AF:
0.00307
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00281
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.00211
Hom.:
0
Bravo
AF:
0.00189
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.00234
AC:
9
ESP6500AA
AF:
0.00101
AC:
4
ESP6500EA
AF:
0.00202
AC:
16
ExAC
AF:
0.00123
AC:
142
EpiCase
AF:
0.00278
EpiControl
AF:
0.00225

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:9
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:5
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsJun 10, 2019- -
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicDec 10, 2018- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJun 01, 2023NHLRC1: BS2 -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Likely benign, criteria provided, single submitterclinical testingGeneDxMay 11, 2021- -
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Apr 03, 2014- -
Lafora disease Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitterclinical testingRevvity Omics, RevvityNov 09, 2020- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 28, 2024- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsFeb 29, 2024This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
NHLRC1-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesOct 24, 2019This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
3.4
DANN
Benign
0.54
DEOGEN2
Benign
0.17
T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.34
T
M_CAP
Uncertain
0.091
D
MetaRNN
Benign
0.0068
T
MetaSVM
Benign
-0.44
T
MutationAssessor
Benign
1.4
L
MutationTaster
Benign
1.0
N
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
-1.5
N
REVEL
Benign
0.26
Sift
Benign
1.0
T
Sift4G
Benign
0.54
T
Polyphen
0.0020
B
Vest4
0.085
MVP
0.64
MPC
0.47
ClinPred
0.0052
T
GERP RS
0.95
Varity_R
0.058
gMVP
0.50

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139029314; hg19: chr6-18122806; API